BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21717227)

  • 1. [Loss of visual acuity after treatment with pipamperone].
    Loos D; Kook P; Huber J; Zorn C; Lohmann CP; Zapp D; Maier M
    Ophthalmologe; 2011 Aug; 108(8):763-5. PubMed ID: 21717227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Psychodynamic and sociodynamic changes produced by methylperidol].
    Leal R
    Actas Luso Esp Neurol Psiquiatr; 1969 Oct; 28(4):299-305. PubMed ID: 5394271
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical trial with R-3345].
    Bastos O; Carvalho RG
    J Bras Psiquiatr; 1970; 19(3):251-6. PubMed ID: 4949175
    [No Abstract]   [Full Text] [Related]  

  • 4. Pipamperone (Dipiperon), a useful sedative neuroleptic drug in troublesome chronic psychotic patients.
    Squelart P; Saravia J
    Acta Psychiatr Belg; 1977; 77(2):284-93. PubMed ID: 906888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary clinical observations on a new butyrophenone derivative: Dipiperon on Pipamperone (R-3345)].
    Madalena JC
    Hospital (Rio J); 1967 Jan; 71(1):73-8. PubMed ID: 5302873
    [No Abstract]   [Full Text] [Related]  

  • 6. Character neuroses and behavioural disorders in children: their treatment with pipamperone (Dipiperon). A clinical study.
    Van Renynghe de Voxvrie G; De Bie M
    Acta Psychiatr Belg; 1976; 76(4):688-95. PubMed ID: 1020694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical report on a high potency neuroleptic agent with certain specific 24-hour-effect after oral administration].
    Zick WH
    Med Welt; 1969 Jul; 30():1659-61. PubMed ID: 5355657
    [No Abstract]   [Full Text] [Related]  

  • 8. [On the question of possible irreversible disorders due to psychopharmacotherapy].
    Meyer HH
    Arch Psychiatr Nervenkr (1970); 1966; 208(4):345-59. PubMed ID: 5969585
    [No Abstract]   [Full Text] [Related]  

  • 9. A pilot study of AL-1021 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):775-8. PubMed ID: 4984042
    [No Abstract]   [Full Text] [Related]  

  • 10. [Atypical neuroleptics, pharmacology and clinical importance].
    Klages U; Hippius H; Müller-Spahn F
    Fortschr Neurol Psychiatr; 1993 Nov; 61(11):390-8. PubMed ID: 7903656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation.
    Deberdt R
    Acta Psychiatr Belg; 1976; 76(1):157-66. PubMed ID: 970185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Character disorders and their treatment by pipamperone].
    Fouks ; Périvier ; Houssalt ; Gilbert ; Ferragu
    Ann Med Psychol (Paris); 1968 Feb; 1(2):255-8. PubMed ID: 5651948
    [No Abstract]   [Full Text] [Related]  

  • 13. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Enuresis in therapy with psychotropic drugs].
    Zahno A; Ramseier E; Hruz P
    Praxis (Bern 1994); 2007 Sep; 96(36):1357-8. PubMed ID: 17894120
    [No Abstract]   [Full Text] [Related]  

  • 15. Experience with a new butyrophenone derivative (Buronil).
    Vangtorp A; Simmelsgaard H; Mellegaard M
    Acta Psychiatr Scand Suppl; 1968; 203():235-8. PubMed ID: 4881877
    [No Abstract]   [Full Text] [Related]  

  • 16. Clastogenic effects of haloperidol in vivo and of haloperidol, droperidol, and pipamperone in vitro. A negative study.
    van den Berghe H
    Arzneimittelforschung; 1974 Dec; 24(12):2055-8. PubMed ID: 4615717
    [No Abstract]   [Full Text] [Related]  

  • 17. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 18. Treating severe maladjustment with pipamperone (Dipiperon).
    Noordhuizen GJ
    Acta Psychiatr Belg; 1977; 77(6):754-60. PubMed ID: 610354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pilot study on the use of AL-1021 in the treatment of chronic schizophrenia.
    Angus JW; Go SH; Simpson GM
    Curr Ther Res Clin Exp; 1969 Dec; 11(12):779-83. PubMed ID: 4984043
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.